Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Rheumatoid arthritis (RA) patients taking Remicade (infliximab) can safely switch to CT-P13 (developed by Celltrion) — a much cheaper biosimilar of Remicade — according to a Norwegian study published in The Lancet. ... Read more
The European League Against Rheumatism (EULAR) has recommended the use of janus kinase (JAK) protein inhibitors, such as Pfizer’s Xeljanz (tofacitinib citrate), for the management of rheumatoid arthritis (RA). EULAR’s ... Read more
Rheumatoid Arthritis News interviewed Dr. Ara Dikranian, a rheumatologist at the Cabrillo Center for Rheumatic Disease in El Cajon, California, about his experience in talking with rheumatoid arthritis (RA) ... Read more
Vaccination against pneumococcal pneumonia may not protect patients with rheumatoid arthritis (RA) at risk of infection from pneumonia, according to the results of a clinical trial in Japan. The ... Read more
Kevzara (sarilumab) has been approved in Canada as a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) who are either intolerant or considered inappropriate candidates to be ... Read more
A bacterium that causes gum infections may also contribute to inflammation leading to chronic joint-destroying rheumatoid arthritis (RA), according to new research. This could provide useful information on how ... Read more
Pin It on Pinterest